<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05014581</url>
  </required_header>
  <id_info>
    <org_study_id>PREVENTION</org_study_id>
    <nct_id>NCT05014581</nct_id>
  </id_info>
  <brief_title>Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation</brief_title>
  <acronym>PREVENTION</acronym>
  <official_title>Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation. The PREVENTION Randomized Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera San Gerardo di Monza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera San Gerardo di Monza</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tracheal intubation (TI) is associated with a high risk of adverse events in critically ill&#xD;
      patients and peri-intubation hemodynamic collapse is the most commonly observed. The primary&#xD;
      aim of the PREVENTION trial is to compare the effect of the pre-emptive use of noradrenaline&#xD;
      versus no peri-intubation use of noradrenaline on incidence of cardiovascular collapse&#xD;
      following TI in adult critically ill patients. Patients with absolute indication or&#xD;
      contraindication to vasopressor support will be excluded from this trial. Patients will be&#xD;
      randomized 1:1 to a continuous infusion of noradrenaline started before induction titrated to&#xD;
      the goal of MAP 100 mmHg. The primary outcome will be the incidence of cardiovascular&#xD;
      collapse. Secondary outcomes will include lowest systolic blood pressure within 30 minutes,&#xD;
      ICU and in-hospital mortality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PREVENTION trial is a pragmatic, multi-center, un-blinded, parallel group, randomized study&#xD;
      comparing the pre-emptive use of noradrenaline to no-vasopressors during the peri-intubation&#xD;
      period of adult critically ill patients. Investigators hypothesize that the pre-emptive&#xD;
      administration of noradrenaline would mitigate the incidence and severity of peri-intubation&#xD;
      cardiovascular collapse. The study will include adult (18 yrs or older) critically ill&#xD;
      patients needing in-hospital intubation, excluding patients with absolute indication or&#xD;
      contraindication to vasopressors. Patients will be randomized to receive either a continuous&#xD;
      infusion of noradrenaline to reach the mean arterial pressure (MAP) goal of 100 mmHg vs no&#xD;
      vasopressors during the peri-intubation period. All co-interventions will be provided&#xD;
      according to clinician's judgement. The primary outcome of the study will be a composite of&#xD;
      MAP &lt; 60 mmHg or cardiac arrest. Secondary outcomes will include lowest systolic blood&#xD;
      pressure &lt; 30 minutes from induction, change in systolic blood pressure from baseline to the&#xD;
      lowest value within 30 minutes from induction and ICU mortality.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with cardiovascular collapse</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Composite outcome of mean arterial pressure &lt; 60 mmHg or cardiac arrest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with MAP &lt; 60 mmHg</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Mean arterial pressure &lt; 60 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with cardiac arrest</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Development of either a shockable or non shockable rhythm associated with cardiac arrest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lowest value of SBP</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Lowest systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with SBP &lt; 65 mmHg</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Systolic blood pressure &lt; 65 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total volume (ml) of administered fluids</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Total volume of fluids administered from induction to 30 minutes to maintain the hemodynamic target</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with death within 30 minutes from induction</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Cardiac arrest without return of spontaneous circulation and death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SBP value from last value before induction to lowest value</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Drop of the systolic blood pressure from baseline value to the lowest value registered by 30 minutes from induction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lowest value SpO2 %</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Lowest peripheral oxygen saturation registered between induction and 30 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with first pass intubation success</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Confirmed successful intubation after a single laryngoscopy attempt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with first pass success without adverse events</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Confirmed successful intubation with a single laryngoscopy attempt without peri-intubation cardiovascular collapse and severe hypoxemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with hypoxemia</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>SpO2 &lt; 90%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with severe hypoxemia</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>SpO2 &lt; 80%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with need for new start of renal replacement therapy</measure>
    <time_frame>28 days from intubation</time_frame>
    <description>Development of acute renal failure with need of new start of renal replacement therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU free days</measure>
    <time_frame>28 days from intubation</time_frame>
    <description>Days with a patient alive and without admission to an intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>28 days from intubation</time_frame>
    <description>Death during the ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator free days</measure>
    <time_frame>28 days from intubation</time_frame>
    <description>Days with a patient alive and free from mechanical ventilation support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>28 days from intubation</time_frame>
    <description>Death during the hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lowest SBP value in the 24 hours after intubation</measure>
    <time_frame>24 hours from intubation</time_frame>
    <description>Lowest systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest dose of vasopressor in the 24 hours after intubation</measure>
    <time_frame>24 hours from intubation</time_frame>
    <description>Highest dose of any vasopressor administered as a continuous infusion (mcg/Kg/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasopressor-free days up to 28 days</measure>
    <time_frame>28 days from intubation</time_frame>
    <description>Days without any continuous infusion of vasopressors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lowest oxygen saturation in the 24 hours after intubation</measure>
    <time_frame>24 hours from intubation</time_frame>
    <description>Lowest peripheral oxygen saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest fraction of inspired oxygen in the 24 hours after intubation</measure>
    <time_frame>24 hours from intubation</time_frame>
    <description>Highest fraction of inspired oxygen during invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest PEEP value in the 24 hours after intubation</measure>
    <time_frame>24 hours from intubation</time_frame>
    <description>Highest value of positive end expiratory pressure (cmH2O) during invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluid balance of the first 24 hours following intubation</measure>
    <time_frame>24 hours from intubation</time_frame>
    <description>Positive or negative fluid balance in milliliters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with severe hypertension</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Systolic blood pressure of 180 mmHg or higher or diastolic blood pressure of 120 mmHg or higher</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with cardiac arrhythmias</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Occurrence of any supraventricular or ventricular arrhythmia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with bradycardia</measure>
    <time_frame>30 minutes from induction</time_frame>
    <description>Heart rate &lt; 60 beats per minute</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">420</enrollment>
  <condition>Critical Illness</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Pre-emptive vasopressor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pre-emptive continuous infusion of norepinephrine during intubation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No vasopressor</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No pre-emptive administration of vasopressors</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Noradrenaline</intervention_name>
    <description>Pre-emptive continuous infusion of noradrenaline during the peri-intubation period</description>
    <arm_group_label>Pre-emptive vasopressor</arm_group_label>
    <other_name>Norepinephrine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is admitted or scheduled for admission to a participating study hospital&#xD;
&#xD;
          -  Planned procedure is tracheal intubation and planned operator is a provider expected&#xD;
             to routinely perform endotracheal intubation in the participating unit&#xD;
&#xD;
          -  Critical illness (i.e. life-threatening condition with intubation required for&#xD;
             cardiorespiratory failure or neurological impairment)&#xD;
&#xD;
          -  Administration of sedation (with or without neuromuscular blockade) is planned&#xD;
&#xD;
          -  Age 18 years or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Operator feels vasopressor support is absolutely indicated or contraindicated in the&#xD;
             patient&#xD;
&#xD;
          -  Urgency of intubation precludes safe performance of study procedures&#xD;
&#xD;
          -  Intubation performed during cardiopulmonary resuscitation of a patient in cardiac&#xD;
             arrest&#xD;
&#xD;
          -  Pregnant or suspected pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincenzo Russotto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital San Gerardo Monza, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John G Laffey, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Galway, NUI Galway, Ireland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vincenzo Russotto, MD</last_name>
    <phone>+393297893044</phone>
    <email>vincenzo.russotto@unimib.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Giacomo Bellani, MD, PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jean Baptiste Lascarrou, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galway University Hospitals</name>
      <address>
        <city>Galway</city>
        <country>Ireland</country>
      </address>
    </facility>
    <contact>
      <last_name>John G Laffey, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital San Gerardo</name>
      <address>
        <city>Monza</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Giacomo Bellani, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Ireland</country>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Russotto V, Myatra SN, Laffey JG, Tassistro E, Antolini L, Bauer P, Lascarrou JB, Szuldrzynski K, Camporota L, Pelosi P, Sorbello M, Higgs A, Greif R, Putensen C, Agvald-Ã–hman C, Chalkias A, Bokums K, Brewster D, Rossi E, Fumagalli R, Pesenti A, Foti G, Bellani G; INTUBE Study Investigators. Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries. JAMA. 2021 Mar 23;325(12):1164-1172. doi: 10.1001/jama.2021.1727. Erratum in: JAMA. 2021 May 24;:null.</citation>
    <PMID>33755076</PMID>
  </results_reference>
  <results_reference>
    <citation>Russotto V, Myatra SN, Laffey JG. What's new in airway management of the critically ill. Intensive Care Med. 2019 Nov;45(11):1615-1618. doi: 10.1007/s00134-019-05757-0. Epub 2019 Sep 16.</citation>
    <PMID>31529354</PMID>
  </results_reference>
  <results_reference>
    <citation>Janz DR, Casey JD, Semler MW, Russell DW, Dargin J, Vonderhaar DJ, Dischert KM, West JR, Stempek S, Wozniak J, Caputo N, Heideman BE, Zouk AN, Gulati S, Stigler WS, Bentov I, Joffe AM, Rice TW; PrePARE Investigators; Pragmatic Critical Care Research Group. Effect of a fluid bolus on cardiovascular collapse among critically ill adults undergoing tracheal intubation (PrePARE): a randomised controlled trial. Lancet Respir Med. 2019 Dec;7(12):1039-1047. doi: 10.1016/S2213-2600(19)30246-2. Epub 2019 Oct 1.</citation>
    <PMID>31585796</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 10, 2021</study_first_submitted>
  <study_first_submitted_qc>August 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>August 14, 2021</last_update_submitted>
  <last_update_submitted_qc>August 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera San Gerardo di Monza</investigator_affiliation>
    <investigator_full_name>Vincenzo Russotto, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>tracheal intubation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

